{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:21:58Z","timestamp":1777929718579,"version":"3.51.4"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T00:00:00Z","timestamp":1240185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2009,4,20]],"date-time":"2009-04-20T00:00:00Z","timestamp":1240185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Onkologie"],"abstract":"<jats:p>102 Patienten mit malignen Tumoren minderer Strahlensensibilit\u00e4t wurden seit 1972 einer kombinierten lokalen Hyperthermie-\u03b3-Strah-lenbehandlung unterzogen. Es handelte sich meist um Tumoren des Oberfl\u00e4chen-Halbtiefentherapiebereichs. Die Behandlungsergebnisse werden auf Tumorr\u00fcckbildung, \u00f6rtliche Rezidive und Metastasierungs-h\u00e4ufigkeit nach Behandlungsabschlu\u00df hin untersucht. Es ergaben sich erwartungsgem\u00e4\u00df gute R\u00fcckbildungen, geringe lokale Rezidivquoten (11 %) und keine erh\u00f6hte Fernmetastasierung durch die Hyperthermie. Eine \u00c4nderung des Bestrahlungsrhythmus war nicht erforderlich. Bemerkenswert war die ungew\u00f6hnlich gute Gewebevertr\u00e4glichkeit. Die Hyperthermie kann besonders vorteilhaft in Kombination mit Strahlenarten mit niedrigem LET angewandt werden.<\/jats:p>","DOI":"10.1159\/000214868","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T10:40:22Z","timestamp":1240396822000},"page":"6-9","source":"Crossref","is-referenced-by-count":0,"title":["Kombinierte W\u00e4rme-Strahlentherapie maligner Tumoren"],"prefix":"10.1159","author":[{"given":"Ursula","family":"Weischedel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuno","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2009,4,20]]},"container-title":["Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/214868","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000214868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:50:57Z","timestamp":1777679457000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000214868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,20]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000214868","archive":["Portico"],"relation":{},"ISSN":["0378-584X","1423-0240"],"issn-type":[{"value":"0378-584X","type":"print"},{"value":"1423-0240","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,20]]}}}